Table 3.

MT201-dependent cytotoxicity results in ovarian cancer cell lines

Cell line	Control ± SD	Rituximab ± SD	MT201 ± SD	p-value*
OSPC-ARK-1	2.5% ± 1.5	2.4% ± 1.4	61.8% ± 18.7
OSPC-ARK-2	7.4% ± 6.5	6.2% ± 4.4	60.8% ± 9.2
OSPC-ARK-3	3.7% ± 3.6	3.3% ± 2.9	4.6% ± 6.5
OSPC-ARK-4	1.6% ± 1.4	1.9% ± 0.6	47.0% ± 24.1
OSPC-ARK-5	5.5% ± 1.6	0.7% ± 0.9	6.7% ± 3.5
CC-ARK-1	2.4% ± 1.4	4.0% ± 2.5	54.8% ± 17.2
CC-ARK-2	2.7% ± 2.0	1.6% ± 1.4	50.6% ± 21.8
Average**	3.7% ± 2.6	2.9% ± 2.0	40.9 ± 14.4	<0.0001

^*Cytotoxicity results in EpCAM-positive cell lines versus controls by Kruskal-Wallis test.

^**Average of 36 cytotoxicity experiments.